Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8422773.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To test the clinical use of octreotide in the treatment of sulfonylurea-induced hypoglycemia. A case is reported of sulfonylurea-induced hypoglycemic coma in a nondiabetic subject, which was complicated by relapse of hypoglycemia after resuscitation with intravenous dextrose. Subcutaneous octreotide, 50 micrograms 12 hourly, suppressed stimulated endogenous insulin secretion, thereby preventing a further recurrence of hypoglycemia. No adverse effects of treatment were observed. These results suggest a significant role for octreotide as an adjunct to intravenous dextrose in the management of severe and refractory cases of sulfonylurea-induced hypoglycemia.
Medical subject headings
- Hypoglycemia
- Octreotide
- Tolbutamide